Aug 2026· Diabetes, obesity and metabolism· Vol 28, pp. 10183 - 10194· 0 citations· 39 references
Medicine
Abstract
To further characterise the effects of retatrutide on cardiometabolic risk, lipoprotein and inflammatory biomarkers were assessed post hoc in phase 2 trials of adults with obesity/overweight with or without type 2 diabetes (T2D).
To examine whether insulin resistance (IR), assessed by cumulative triglyceride–glucose (TyG)‐derived indices and change patterns, stratifies incident cardiovascular disease (CVD) risk after glycaemic transition in adults with prediabetes.
Hui-Qiang Cai, Yi Fu, Fang-Ge Zhu et al.· Diabetes, obesity and metabo...· 0 citations
Chronic inflammation and insulin resistance (IR) are key drivers of cardiovascular disease (CVD); however, their joint impact on cardiovascular risk remains poorly understood.
Meng-Lu Liu, N. Xu, Geng-Yu Sha et al.· Diabetes, obesity and metabo...· 0 citations
This network meta‐analysis addresses the limited dose‐specific comparative evidence by evaluating different doses of tirzepatide (TZP) versus dulaglutide (DULA) for glycemic control, weight loss, and safety in type 2 diabetes mellitus (T2DM).
A. Hageen, A. Gadelmawla, A. O. Saleh et al.· Endocrinology, Diabetes & Me...· 0 citations
To evaluate changes in glycaemic control following semaglutide discontinuation in adults with Type 1 diabetes and obesity who completed the ADJUST‐T1D randomised controlled trial.
Eslam Montaser, K. Bhasin, Davida F. Kruger et al.· Diabetes, obesity and metabo...· 0 citations
Whether psPRS for beta cell dysfunction, obesity and metabolic syndrome associate with risk of hyperglycaemic progression in Southeast Asian patients with type 2 diabetes is studied.
Sylvia Liu, Hui-Li Zheng, Jia Le Ivan Tan et al.· Diabetes, obesity and metabo...· 0 citations
Waist circumference (WC) and grip strength (GS) are independently associated with atherosclerotic cardiovascular disease (ASCVD) risk. However, their joint impact remains insufficiently explored. This study aimed to investigate the association between WC, GS and ASCVD risk and to explore the underlying mediating factor...
Jie Luo, Yin Wang, Zhao-Fu Tan et al.· Diabetes, obesity and metabo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.